We previously reported that CDC25A drives integrin-dependent proliferation of AML cells9, and is up-regulated downstream of oncogenic mutated tyrosine kinases NPM-ALK, BCR-ABL and JAK2V617F in different lymphoid and myeloid malignancies10,11. This evidence concerns the gene CDC25A and acute myeloid leukemia.